文献速递神经肿瘤脑血管病外科神经重症

他汀使用与高脂血症胶质瘤患者颅脑放疗后卒中风险降低相关

Statin use is associated with reduced stroke risk after cranial radiation in glioma patients with hyperlipidemia.
PubMed 文献 · J Neurooncol · 2026-04-22

该回顾性研究纳入2005至2021年接受颅脑放疗的成人胶质瘤合并高脂血症患者297例,采用Cox比例风险模型以死亡为竞争事件评估他汀暴露对卒中发生的影响。结果显示,65例(21.9%)发生卒中,他汀使用与卒中风险降低独立相关(HR 0.36,95%CI 0.21-0.61,p<0.001),诊断时年龄增加与卒中风险升高独立相关(HR 1.03,95%CI 1.00-1.05,p=0.02)。

要点

  • 胶质瘤合并高脂血症患者放疗后卒中并不少见,本队列发生率为21.9%。
  • 他汀使用与卒中风险降低独立相关,HR 0.36(95%CI 0.21-0.61,p<0.001)。
  • 诊断时年龄较大与卒中风险升高独立相关,HR 1.03(95%CI 1.00-1.05,p=0.02)。

核心结论

  • 在接受颅脑放疗的胶质瘤合并高脂血症患者中,他汀治疗与较低的卒中风险相关,提示他汀可能对放疗后脑血管损伤具有潜在保护作用。

研究设计与样本

  • 回顾性研究,纳入2005至2021年接受颅脑放疗的成人胶质瘤合并高脂血症患者,共297例,自放疗时随访至末次随访。
  • 采用Cox比例风险模型评估他汀暴露与新发卒中的关系,并将死亡作为竞争事件。

主要发现

  • 297例接受颅脑放疗且合并高脂血症的患者中,65例(21.9%)发生卒中。
  • 诊断时年龄增加与卒中风险升高独立相关(HR 1.03,95%CI 1.00-1.05,p=0.02)。
  • 他汀使用与卒中风险降低独立相关(HR 0.36,95%CI 0.21-0.61,p<0.001)。

临床怎么用

  • 对接受颅脑放疗的胶质瘤合并高脂血症患者,可将他汀使用纳入脑血管风险管理的考量。
  • 研究结果支持进一步开展前瞻性研究,以明确血脂管理是否应纳入神经肿瘤诊疗中的脑血管风险降低策略。

局限性

  • 为回顾性研究,他汀暴露与卒中风险的关联可能受混杂因素影响。
  • 高脂血症基于卒中时病历回顾确诊,可能存在选择与信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Cranial radiation is a cornerstone in management of glioma though is associated with increased stroke risk. Hyperlipidemia has previously been found to be associated with increased stroke risk in this population. This study aimed to evaluate whether statin use is associated with reduced stroke risk in patients with glioma and hyperlipidemia who underwent cranial radiation. METHODS: We conducted a retrospective study of adult patients with glioma and hyperlipidemia who received cranial radiation between 2005 and 2021. Data were collected from time of cranial radiation until last follow-up. Patients diagnosed with hyperlipidemia through review of medical records at time of stroke were included in the analysis. Cox-proportional hazards modeling was performed to evaluate incident stroke with death as a competing event to evaluate the impact of statin exposure on stroke. RESULTS: In a cohort of 297 patients that received cranial radiation and had hyperlipidemia, 65 (21.9%) experienced stroke. Increasing age at diagnosis was independently associated with higher stroke risk (HR 1.03, 95% CI 1.00-1.05, p = 0.02) while statin use was independently associated with lower risk of stroke (HR 0.36, 0.21-0.61, p < 0.001). DISCUSSION: In a cohort of glioma patients with hyperlipidemia treated with cranial radiation, statin therapy was associated with lower stroke risk. These findings suggest a potential protective effect of statins against cerebrovascular injury in radiated patients. Prospective studies are warranted to explore whether lipid management should be incorporated into cerebrovascular risk reduction strategies in neuro-oncology care.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Ryan D, Peters KB, Sengupta S, et al. Statin use is associated with reduced stroke risk after cranial radiation in glioma patients with hyperlipidemia. J Neurooncol. 2026. PMID: 42018085. doi:10.1007/s11060-026-05586-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。